Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials

BACKGROUND: Add-on prolonged-release melatonin (PRM) in antihypertensive therapy has been shown to ameliorate nocturnal hypertension. Hypertension is a major comorbidity among insomnia patients. The efficacy and safety of PRM for primary insomnia in patients aged 55 years and older who are treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemoine, Patrick, Wade, Alan G, Katz, Amnon, Nir, Tali, Zisapel, Nava
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278206/
https://www.ncbi.nlm.nih.gov/pubmed/22346363
http://dx.doi.org/10.2147/IBPC.S27240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278206/
https://www.ncbi.nlm.nih.gov/pubmed/22346363
http://dx.doi.org/10.2147/IBPC.S27240

Ejemplares similares